期刊文献+

产后出血伴发凝血功能障碍的相关危险因素分析 被引量:3

Analysis of risk factors related to postpartum hemorrhage combined with coagulation dysfunction
下载PDF
导出
摘要 目的分析产后出血伴发凝血功能障碍的一般情况及相关危险因素,提高临床医生对产后出血高危因素的认识和救治。方法回顾性分析我院2016年1月~2018年12月产科MICU收治的产后出血伴发凝血功能障碍的产妇58例作为观察组,按照出血量多少(<30%,30%~50%,51%~70%,>70%)分成四组,比较各组在活化部分凝血活酶时间(APTT)、凝血酶原时间(PT)、纤维蛋白原(Fib)、血红蛋白(HB)、血小板(Plt)水平差异;同时选择同期产后出血没有伴发凝血功能障碍的产妇59例作为对照组,对产后出血相关危险因素行Logistic回归分析。结果在观察组中四组凝血指标比较无明显统计学差异;在产后出血高危因素中,瘢痕子宫、前置胎盘、胎盘植入在观察组与对照组两组之间比较差异有统计学意义(P<0.05),Logistic回归分析显示瘢痕子宫、胎盘植入与产后出血伴发凝血功能障碍明显相关(OR=4.249,95%CI=1.506~11.984,P=0.006;OR=5.880,95%CI=1.551~22.296,P=0.009)。结论瘢痕子宫、胎盘植入与产后出血早期凝血功能障碍明显相关,是产后出血早期出现凝血功能障碍的高危因素。 Objective To analyze the general situation and related risk factors of postpartum hemorrhage accompanied by coagulation dysfunction,and to improve clinicians'understanding of high risk factors and treatment for postpartum hemorrhage.Methods Fifty-eight cases of postpartum hemorrhage combined with coagulation dysfunction from January 2016 to December 2018 were selected as the observation group,and were divided into four groups according to the amount of bleeding(<30%,30%-50%,51%-70%,>70%).The levels of activated partial thromboplastin time(APTT),prothrombin time(PT),fibrinogen(Fib),hemoglobin(HB),and platelet(Plt)between groups were compared.At the same time,59 women with postpartum hemorrhage who had no coagulation dysfunction during the same period were selected as the control group.Logistic regression analysis was performed on risk factors related to postpartum hemorrhage.Results In the observation group,there was no significant statistical difference between the four groups of coagulation indicators.Among the high risk factors for postpartum hemorrhage,there were statistically significant differences in scar uterus,placenta previa,and placenta accreta between the observation group and the control group(P<0.05).Logistic regression analysis showed that scar uterus and placenta accreta were significantly associated with postpartum hemorrhage accompanied by coagulation dysfunction(OR=4.249,95%CI=1.506-11.984,P=0.006;OR=5.880,95%CI=1.551-22.296,P=0.009).Conclusion Scar uterus and placenta accreta are significantly related to coagulation dysfunction in early postpartum hemorrhage,and are high-risk factors for coagulation dysfunction in early postpartum hemorrhage.
作者 王永梅 汪剑 孟荔 史爱武 WANG Yongmei;WANG Jian;MENG Li;SHI Aiwu(Medical Intensive Care Unit,Nanjing Medical University Obstetrics and Gynecology Hospital,Nanjing Maternal and Child Health Hospital,Nanjing210004,China)
出处 《中国现代医生》 2020年第18期82-84,88,共4页 China Modern Doctor
基金 南京医科大学科技发展基金项目(NMUB2019216)。
关键词 产后出血 凝血功能障碍 瘢痕子宫 胎盘植入 Postpartum hemorrhage Coagulation dysfunction Scarred uterus Placenta implantation
  • 相关文献

参考文献7

二级参考文献132

  • 1梁辉,王德祥,王保国.患者大量输血时凝血功能的监测和维持[J].中国急救医学,2004,24(10):756-758. 被引量:15
  • 2陈方祥,何静,刘建忠,袁玲,马桂山,陈钧.大量输血病例分析[J].创伤外科杂志,2004,6(6):425-427. 被引量:5
  • 3刘景汉,周俊,卢发强,潘纪春,马曙轩.100例肝移植患者围手术期输血疗效分析[J].中国医师杂志,2006,8(7):908-910. 被引量:5
  • 4卫生部医政司.临床输血技术规范.卫医发[2000]第184号,2000-10-01.
  • 5中华人民共和国卫生部令第85号.医疗机构临床用血管理办 法-2012 08 01.
  • 6中华人民共和国卫生部.血站基本标准.卫医发[2000]448号.
  • 7Stainsby D,MacLennan S,Hiomas D,et al. Guidelines on the management of massive blood loss. Br Commit Stand Haematol, 2006, 135(5) :634-641.
  • 8Stainsby D,MacLennan S,Hamilton PJ,et al. Management of massive blood loss : a template guideline. Br J Anaesth, 2000,85 (3); 487-491.
  • 9Kozek-Langenecker S. Management of massive operative blood loss. Minerva Anestesiol,2007,73(7) *401 -415.
  • 10Samama CM,Djoudi R,Lecompte T. Perioperative platelet transfusion. recommendations of the French Health Products Safety Agency (AFSSAPS) 2003. Minerva Anestesiol,2006 ,72(6) ;447-452.

共引文献996

同被引文献31

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部